MENU

Omicron: Pfizer-BioNTech COVID-19 vaccine may only partially protect against new variant, study suggests

A new study led by the Africa Health Research Institute reportedly suggests that the omicron COVID-19 variant escapes antibody immunity induced by two doses of the Pfizer-BioNTech vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story